Thomas Jefferson University

Wayne Pinover

TitleAssoc Professor
InstitutionThomas Jefferson University
DepartmentRadiation Oncology
Address1200 Old York Road
Abington PA 19001
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, Daly MB, Mohler JL, Parsons JK, Carroll PR, Pilarski R, Blanco A, Woodson A, Rahm A, Taplin ME, Polascik TJ, Helfand BT, Hyatt C, Morgans AK, Feng F, Mullane M, Powers J, Concepcion R, Lin DW, Wender R, Mark JR, Costello A, Burnett AL, Sartor O, Isaacs WB, Xu J, Weitzel J, Andriole GL, Beltran H, Briganti A, Byrne L, Calvaresi A, Chandrasekar T, Chen DYT, Den RB, Dobi A, Crawford ED, Eastham J, Eggener S, Freedman ML, Garnick M, Gomella PT, Handley N, Hurwitz MD, Izes J, Karnes RJ, Lallas C, Languino L, Loeb S, Lopez AM, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann M, Mille P, Miner MM, Morgan T, Moreno J, Mucci L, Myers RE, Nielsen SM, O'Neil B, Pinover W, Pinto P, Poage W, Raj GV, Rebbeck TR, Ryan C, Sandler H, Schiewer M, Scott EMD, Szymaniak B, Tester W, Trabulsi EJ, Vapiwala N, Yu EY, Zeigler-Johnson C, Gomella LG. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. J Clin Oncol. 2020 Jun 09; JCO2000046. PMID: 32516092.
      Citations:    
    2. Lukka HR, Pugh SL, Bruner DW, Bahary JP, Lawton CAF, Efstathiou JA, Kudchadker RJ, Ponsky LE, Seaward SA, Dayes IS, Gopaul DD, Michalski JM, Delouya G, Kaplan ID, Horwitz EM, Roach M, Pinover WH, Beyer DC, Amanie JO, Sandler HM, Kachnic LA. Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 10 01; 102(2):287-295. PMID: 29913254.
      Citations:    
    3. Konski A, Garcia M, John M, Krieg R, Pinover W, Myerson R, Willett C. Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08. Int J Radiat Oncol Biol Phys. 2008 Sep 01; 72(1):114-8. PMID: 18472363.
      Citations:    
    4. Manne S, Babb J, Pinover W, Horwitz E, Ebbert J. Psychoeducational group intervention for wives of men with prostate cancer. Psychooncology. 2004 Jan; 13(1):37-46. PMID: 14745744.
      Citations:    
    5. Uzzo RG, Pinover WH, Horwitz EM, Parlanti A, Mazzoni S, Raysor S, Mirchandani I, Greenberg RE, Pollack A, Hanks GE, Watkins-Bruner D. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination. Urology. 2003 Apr; 61(4):754-9. PMID: 12670560.
      Citations:    
    6. Pinover WH, Horwitz EM, Hanlon AL, Uzzo RG, Hanks GE. Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapy. Cancer. 2003 Feb 15; 97(4):1127-33. PMID: 12569615.
      Citations:    
    7. Horwitz EM, Mitra RK, Uzzo RG, Das IJ, Pinover WH, Hanlon AL, McNeeley SW, Hanks GE. Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants. Radiother Oncol. 2003 Feb; 66(2):173-9. PMID: 12648789.
      Citations:    
    8. Chism DB, Horwitz EM, Hanlon AL, Pinover WH, Mitra RK, Hanks GE. Late morbidity profiles in prostate cancer patients treated to 79-84 Gy by a simple four-field coplanar beam arrangement. Int J Radiat Oncol Biol Phys. 2003 Jan 01; 55(1):71-7. PMID: 12504038.
      Citations:    
    9. Kramer NM, Hanlon AL, Horwitz EM, Pinover WH, Hanks GH. Biochemical failure rates in prostate cancer patients predicted to have biologically insignificant tumors treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys. 2002 Jun 01; 53(2):277-81. PMID: 12023130.
      Citations:    
    10. Price RA, Hanks GE, McNeeley SW, Horwitz EM, Pinover WH. Advantages of using noncoplanar vs. axial beam arrangements when treating prostate cancer with intensity-modulated radiation therapy and the step-and-shoot delivery method. Int J Radiat Oncol Biol Phys. 2002 May 01; 53(1):236-43. PMID: 12007964.
      Citations:    
    11. Kaminski JM, Hanlon AL, Horwitz EM, Pinover WH, Mitra RK, Hanks GE. Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control. Int J Radiat Oncol Biol Phys. 2002 Mar 15; 52(4):888-92. PMID: 11958880.
      Citations:    
    12. Winter DL, Hanlon AL, Raysor SL, Watkins-Bruner D, Pinover WH, Hanks GE, Tricoli JV. Plasma levels of IGF-1, IGF-2, and IGFBP-3 in white and African-American men at increased risk of prostate cancer. Urology. 2001 Oct; 58(4):614-8. PMID: 11597555.
      Citations:    
    13. Movsas B, Chapman JD, Hanlon AL, Horwitz EM, Pinover WH, Greenberg RE, Stobbe C, Hanks GE. Hypoxia in human prostate carcinoma: an Eppendorf PO2 study. Am J Clin Oncol. 2001 Oct; 24(5):458-61. PMID: 11586096.
      Citations:    
    14. Horwitz EM, Hanlon AL, Pinover WH, Anderson PR, Hanks GE. Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniques. Cancer. 2001 Sep 01; 92(5):1281-7. PMID: 11571744.
      Citations:    
    15. Gaspar LE, Winter K, Kocha WI, Pinover WH, Graham M, Gunderson L. Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207). Cancer J. 2001 Sep-Oct; 7(5):388-94. PMID: 11693897.
      Citations:    
    16. Hanlon AL, Pinover WH, Horwitz EM, Hanks GE. Patterns and fate of PSA bouncing following 3D-CRT. Int J Radiat Oncol Biol Phys. 2001 Jul 15; 50(4):845-9. PMID: 11429210.
      Citations:    
    17. Horwitz EM, Pinover WH, Hanks GE. Re: Simultaneous irradiation for prostate cancer: intermediate results with modern techniques. J Urol. 2001 Apr; 165(4):1224. PMID: 11257688.
      Citations:    
    18. Pingpank JF, Hoffman JP, Ross EA, Cooper HS, Meropol NJ, Freedman G, Pinover WH, LeVoyer TE, Sasson AR, Eisenberg BL. Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas. J Gastrointest Surg. 2001 Mar-Apr; 5(2):121-30. PMID: 11331473.
      Citations:    
    19. Movsas B, Chapman JD, Greenberg RE, Hanlon AL, Horwitz EM, Pinover WH, Stobbe C, Hanks GE. Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) study. Cancer. 2000 Nov 01; 89(9):2018-24. PMID: 11064360.
      Citations:    
    20. Hanlon AL, Pinover WH, Horwitz EM, Hanks GE. Regarding Vicini et al., IJROBP 1999,45:553-561. Int J Radiat Oncol Biol Phys. 2000 Jul 15; 47(5):1457-8. PMID: 10939884.
      Citations:    
    21. Pinover WH, Hanlon AL, Horwitz EM, Hanks GE. Defining the appropriate radiation dose for pretreatment PSA < or = 10 ng/mL prostate cancer. Int J Radiat Oncol Biol Phys. 2000 Jun 01; 47(3):649-54. PMID: 10837947.
      Citations:    
    22. Hanks GE, Hanlon AL, Pinover WH, Horwitz EM, Price RA, Schultheiss T. Dose selection for prostate cancer patients based on dose comparison and dose response studies. Int J Radiat Oncol Biol Phys. 2000 Mar 01; 46(4):823-32. PMID: 10705002.
      Citations:    
    23. Horwitz EM, Hanlon AL, Pinover WH, Hanks GE. The cost effectiveness of 3D conformal radiation therapy compared with conventional techniques for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys. 1999 Dec 01; 45(5):1219-25. PMID: 10613316.
      Citations:    
    24. Tricoli JV, Winter DL, Hanlon AL, Raysor SL, Watkins-Bruner D, Pinover WH, Hanks GE. Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancer. Urology. 1999 Jul; 54(1):178-82. PMID: 10414748.
      Citations:    
    25. Hanks GE, Hanlon AL, Pinover WH, Horwitz EM, Schultheiss TE. Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapy. Cancer J Sci Am. 1999 May-Jun; 5(3):152-8. PMID: 10367171.
      Citations:    
    26. Iyer RV, Hanlon AL, Pinover WH, Hanks GE. Outcome evaluation of the 1997 American Joint Committee on Cancer staging system for prostate carcinoma treated by radiation therapy. Cancer. 1999 Apr 15; 85(8):1816-21. PMID: 10223577.
      Citations:    
    27. Algan O, Pinover WH, Hanlon AL, Al-Saleem TI, Hanks GE. Is there a subset of patients with PSA > or = 20 ng/ml who do well after conformal beam radiotherapy? Radiat Oncol Investig. 1999; 7(2):106-10. PMID: 10333251.
      Citations:    
    28. Movsas B, Chapman JD, Horwitz EM, Pinover WH, Greenberg RE, Hanlon AL, Iyer R, Hanks GE. Hypoxic regions exist in human prostate carcinoma. Urology. 1999 Jan; 53(1):11-8. PMID: 9886581.
      Citations:    
    29. Horwitz EM, Hanlon AL, Pinover WH, Hanks GE. Is there a role for short-term hormone use in the treatment of nonmetastatic prostate cancer? Radiat Oncol Investig. 1999; 7(4):249-59. PMID: 10492166.
      Citations:    
    30. Hanks GE, Hanlon AL, Schultheiss TE, Pinover WH, Movsas B, Epstein BE, Hunt MA. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys. 1998 Jun 01; 41(3):501-10. PMID: 9635695.
      Citations:    
    31. Horwitz EM, Hanlon AL, Pinover WH, Hanks GE. The treatment of nonpalpable PSA-detected adenocarcinoma of the prostate with 3-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys. 1998 Jun 01; 41(3):519-23. PMID: 9635697.
      Citations:    
    32. Hanks GE, Hanlon AL, Schultheiss TE, Freedman GM, Hunt M, Pinover WH, Movsas B. Conformal external beam treatment of prostate cancer. Urology. 1997 Jul; 50(1):87-92. PMID: 9218024.
      Citations:    
    33. Hanks GE, Hanlon AL, Pinover WH, al-Saleem TI, Schultheiss TE. Radiation therapy as treatment for stage T1c prostate cancers. World J Urol. 1997; 15(6):369-72. PMID: 9436287.
      Citations:    
    34. Pinover WH, Hanlon A, Lee WR, Kaplan EJ, Hanks GE. Prostate carcinoma patients upstaged by imaging and treated with irradiation. An outcome-based analysis. Cancer. 1996 Apr 01; 77(7):1334-41. PMID: 8608512.
      Citations:    
    Pinover's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (118)
    Explore
    _
    Co-Authors (22)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _